{'fraction_non_alphanumeric': 0.04242700729927007, 'fraction_numerical': 0.017335766423357664, 'mean_word_length': 4.991803278688525, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Paradoxical Effect of IL-18 Therapy on the Severe and Mild Escherichia coli Infections in Burn-Injured Mice

Objective:To investigate the effects of IL-18 therapy on severe and mild bacterial infection after burn injury. Summary Background Data:IL-18 therapy restores IFN-&ggr; production in immunosuppressive mice following burn injury and up-regulate host response to LPS and experimental bacterial peritonitis. On the other hand, the overproduction of IFN-&ggr; could induce an exaggerated inflammation. Therefore, in this study, we focus on the beneficial and deleterious effects of IL-18-induced IFN-&ggr; and investigate the behavior of IL-18 in infections. Methods:Burn injury was induced in C57BL/6 mice and then they were i.p. injected with IL-18 (0.2 &mgr;g) on alternate days. After 1 week, severe and mild infections were made in mice by an Escherichia coli challenge (5 × 108 CFU and 1 × 108 CFU i.v., respectively). Results:IL-18 therapy decreased the mortality of burn-injured mice followed by a severe infection, whereas it unexpectedly increased the mortality of burned mice with a mild infection. The IL-18 therapy increased the number of liver mononuclear cells (MNCs), especially NK cells, and greatly up-regulated the impaired IFN-&ggr; production from the liver and spleen MNCs in mice with severe infection. Both the serum IFN-&ggr; concentrations recovered while the bacterial count in the liver decreased. In contrast, the serum IFN-&ggr; concentrations of the burned mice with mild infection did not decrease in comparison to the unburned mice, whereas IL-18 therapy greatly up-regulated the serum IFN-&ggr; levels in burned mice. However, IL-18 therapy significantly elevated the serum ALT and creatinine levels, thus suggesting that the mortality was induced by an exaggerated form of shock/multiorgan failure. These beneficial and deleterious effects of IL-18 therapy in mice with severe and mild infections, respectively, were all inhibited by anti-IFN-&ggr; Ab pretreatment. Conclusion:IL-18 therapy can be a potent therapeutic tool against severe bacterial infection in immunocompromised hosts, but careful attention should also be paid to its adverse effects.